Evidence map›Paper›PMID 40444466›Full record

ArticlemBio2025

Lack of an atypical PDR transporter generates an immunogenic

Christopher J Winski, Peter V Stuckey, Armando M Marrufo, Georgina Agyei, Robbi L Ross, Tamanna Urmi, Sarah Chapman, Felipe H Santiago-Tirado

Abstract read
In one paragraph

Article in mBio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Set202 is a histone lysine methyltransferase that enablesbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Christopher J WinskiDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Peter V StuckeyDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Armando M MarrufoDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Georgina Agyei *Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Robbi L Ross *Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Tamanna Urmi *Department of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.
Sarah ChapmanIntegrated Imaging Facility, University of Notre Dame, Notre Dame, Indiana, USA.
Felipe H Santiago-TiradoDepartment of Biological Sciences, University of Notre Dame, Notre Dame, Indiana, USA.ORCID 0000-0002-6453-4904

Funding

Host and fungal factors important for the cryptococcal intracellular nicheR01AI177875 · NIAID · UNIVERSITY OF NOTRE DAME · PI Felipe H Santiago-Tirado · 2023 to 2026
$1.6M
The role of a pleiotropic drug resistance (PDR) transporter in the cryptococcal-host interactionsR21AI171742 · NIAID · UNIVERSITY OF NOTRE DAME · PI SANTIAGO-TIRADO, FELIPE H · 2023 to 2024
$430k
NIAID NIH HHS R01 AI177875NIAID NIH HHS R21 AI171742NIH HHS R01AI177875NIH HHS R21AI71742University of Notre Dame
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ATP-Binding Cassette TransportersCryptococcosisCryptococcus neoformansFungal ProteinsLungAnimalsAntifungal AgentsCytokinesDisease Models, AnimalDrug Resistance, FungalFemaleHost-Pathogen InteractionsImmunity, InnateMiceMice, Inbred C57BLVirulenceAntifungal AgentsATP-Binding Cassette TransportersCytokinesFungal ProteinsCryptococcus neoformansfungal immunityfungal pathogenPDR transporter

Identifiers

PMID40444466
PMCPMC12239598

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.